StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Sorrento Therapeutics stock opened at $0.01 on Tuesday. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.42. The company’s 50-day moving average is $0.02 and its 200 day moving average is $0.05.
About Sorrento Therapeutics
Read More
- Five stocks we like better than Sorrento Therapeutics
- What are earnings reports?
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- 3 Fintech Stocks With Good 2021 Prospects
- Generac Powers Ahead on the Electrification Mega-Trend
- Roth IRA Calculator: Calculate Your Potential Returns
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.